Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotation of antihypertensive drugs in predefined ethnic groups
NL-OMON21910Active, not recruiting
- Sponsor
- Menarini Group
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lisinopril, nebivolol, barnidipine, hydrochlorothiazide and eprosartan in hypertension (HTN) (5 arms), sponsored by Menarini Group. Primary endpoints: Office blood pressure and Side effects. Started Jan 2001; status: active, not recruiting.
02
Drugs
lisinoprilnebivololbarnidipinehydrochlorothiazideeprosartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON21910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21910.